CELGENE LEVERAGES ERT eCOA DATA FOR FDA APPROVAL OTEZLA® (apremilast) tablets approved for Active Psoriatic Arthritis in Adults eBook2 CELGENE LEVERAGES ERT eCOA DATA FOR FDA APPROVAL MOBILE eCOA TABLET DEVICES COLLECTED ALL DATA Primary and secondary endpoints were collected using clinician and patient-reported assessments on the eCOA Tablet. On-device calculations, branching and restricted reporting time intervals helped Celgene ensure the completeness and quality of data collected, reduce monitoring time and costs and expedite database lock. ERT EXPERT ® provided easy access to real-time study data with reports on patient enrollment, compliance and safety. ERT eCOA Tablet collects consistent data with universal screen features and functions, mitigating data adjustments recon

Join for free to read